Kite Pharma just received FDA approved for a cell therapy product to treat adults with relapsed or refractory non-hodgkin lymphoma.
http://www.onclive.com/web-exclusives/fda-approves-axicabtagene-ciloleucel-for-nonhodgkin-lymphoma
Gilead Purchased Kite Pharma for $11.9B a couple of months ago.
https://www.cnbc.com/2017/08/28/gil...a-for-about-11-billion-in-cash-dow-jones.html
Just highlighting the activity in the cell therapy space for products and leaders in their field.
Cell Therapy News/Articles, page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.000(0.00%) |
Mkt cap ! $1.113B | |||
| Open | High | Low | Value | Volume |
| $1.51 | $1.52 | $1.49 | $622.4K | 414.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 15936 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 689 | 3 |
View Market Depth
| Last trade - 10.19am 22/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
